percent from the previous quarter. Kyprolis was acquired by Amgen as part of the $10.4 billion purchase of Onyx Pharmaceuticals , which Amgen closed on October 1. The two drugs compete basically for the same multiple myeloma patients
NEW YORK, Nov 22 (Reuters) - Two traders have won the dismissal of a U.S. Securities and Exchange Commission lawsuit accusing them of insider trading in Onyx Pharmaceuticals Inc as the company considered a takeover bid from rival Amgen Inc .
cancers as well as all solid tumor cancers. I first came across Northwest Bio through my past research on Onyx Pharmaceuticals ( ONXX ) and assessing Onyx's potential future competitors with comparable pipelines. Upon looking into Northwest
sclerosis compound. [TICKER:AMGN] Amgen as well, which recently announced an acquisition of [TICKER:VRTX] Onyx Pharmaceuticals , has been strong from an earnings perspective and a stock perspective. And a name like Vertex, which has been
with its internal prospects last quarter when it decided to make the $10 billion debt-funded acquisition of Onyx Pharmaceuticals ONXX (rating: SUS, no moat). This acquisition will boost Amgen's top-line growth by nearly 200 basis points
AMGN ), Onyx Pharamceuticals ( ONXX ), Gilead ( GILD ), Novartis ..... AMGN ) announced it is buying Onyx Pharmaceuticals ( ONXX ) at a 50% premium, and the ..... on the news and those who held ONXX saw huge gains. Two years ago
Best Buy ( BBY ), Dow Chemical ( DOW ), Wynn Resorts ( WYNN ), Humana ( HUM ). Other stocks mentioned: Onyx Pharmaceuticals ( ONXX ), MiX Telematics ( MIXT ), Altria ( MO ), AT&T ( T ), Red Hat ( RHT ) With the Dow declining on Monday
Aug 26 (Reuters) - Investors reacted favorably on Monday to Amgen Inc's $10.4 billion purchase of Onyx Pharmaceuticals Inc, which gives the world's largest biotech company full rights to a blood...
After several weeks of media speculation, Amgen finally announced the acquisition of Onyx Pharmaceuticals for $125 per share, valuing the company at $10.4 billion (or $9.7 billion net of cash). As we stated previously, we
NEW YORK (Reuters) - Amgen Inc, the drugmaker in advanced discussions to buy Onyx Pharmaceuticals Inc, has asked Onyx for some of the data from an ongoing trial on the company's new blood cancer...